Showing 941-960 of 7110 for: Cochrane Systematic Reviews Back
- Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia
Cochrane Systematic Reviews, 9-Aug-2009
This is an update of a previous review (McGuinness 2006).
- Blood pressure targets for hypertension in people with diabetes mellitus
Cochrane Systematic Reviews, 31-Oct-2013
When treating elevated blood pressure (BP), doctors often want to know what blood pressure target they should try to achieve. The standard blood pressure target in clinical practice for some time has been less than 140 - 160/90 - 100 mmHg for the general
- Blood pressure targets for the treatment of people with hypertension and cardiovascular disease
Cochrane Systematic Reviews, 18-Nov-2022
This is the third update of the review first published in 2017.
- Blood pressure-lowering efficacy of loop diuretics for primary hypertension
Cochrane Systematic Reviews, 14-May-2015
Antihypertensive drugs from the thiazide diuretic drug class have been shown to reduce mortality and cardiovascular morbidity. Loop diuretics are indicated and used to treat hypertension, but a systematic review of their blood pressure-lowering efficacy o
- Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension
Cochrane Systematic Reviews, 28-May-2014
Hypertension is a modifiable cardiovascular risk factor. Although it is established that low-dose thiazides reduce mortality as well as cardiovascular morbidity, the dose-related effect of thiazides in decreasing blood pressure has not been subject to a r
- Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease
Cochrane Systematic Reviews, 27-Jul-2020
Sickle cell disease is one of the commonest severe monogenic disorders in the world, due to the inheritance of two abnormal haemoglobin (beta globin) genes. Sickle cell disease can cause severe pain, significant end-organ damage, pulmonary complications,
- Blood transfusion for treating malarial anaemia
Cochrane Systematic Reviews, 2-Aug-2010
Blood transfusion is used in patients with severe malarial anaemia, but risks adverse reactions, transmission of disease, and is complicated to organize in developing countries.
- Blood transfusions for anaemia in patients with advanced cancer
Cochrane Systematic Reviews, 9-Feb-2016
Anaemia occurs in 68% to 77% of patients with advanced cancer, however, only a minority of patients who are admitted to a hospice receive a blood transfusion. It is unclear what the benefit of blood transfusion is in advanced cancer, who is most likely to
- Blood transfusions for treating acute chest syndrome in people with sickle cell disease
Cochrane Systematic Reviews, 14-Sep-2011
Sickle cell disease is an inherited autosomal recessive blood condition and is one of the most prevalent genetic blood diseases worldwide. Acute chest syndrome is a frequent complication of sickle cell disease, as well as a major cause of morbidity and th
- Blue versus white light for transurethral resection of non‐muscle invasive bladder cancer
Cochrane Systematic Reviews, 1-Dec-2021
Disease recurrence and progression remain major challenges in the treatment of non-muscle invasive bladder cancer (NMIBC). Blue light-enhanced transurethral resection of bladder cancer (TURBT) is an approach to improve staging and achieve a complete resec
- Blunt versus sharp suture needles for preventing percutaneous exposure incidents in surgical staff
Cochrane Systematic Reviews, 23-Mar-2016
Surgeons and their assistants are especially at risk of exposure to blood due to glove perforations and needle stick injuries during operations. The use of blunt needles can reduce this risk because they don't penetrate skin easily but still perform suffi
- Body positioning for spontaneously breathing preterm infants with apnoea
Cochrane Systematic Reviews, 15-May-2012
It has been proposed that the use of body positioning may be a more effective way to reduce clinically significant apnoea than the use of more invasive measures.
- Bone grafts and bone substitutes for treating distal radial fractures in adults
Cochrane Systematic Reviews, 23-Mar-2009
Surgical treatment of fractures of the distal radius can involve the implantation of bone scaffolding materials (bone grafts and substitutes) into bony defects that frequently arise after fracture reduction.
- Bone marrow harvest versus peripheral stem cell collection for haemopoietic stem cell donation in healthy donors
Cochrane Systematic Reviews, 30-Oct-2008
Haemopoietic stem cells can be collected from a donor either as a bone marrow harvest or by peripheral blood collection. Both techniques have risks for the donor.
- Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults
Cochrane Systematic Reviews, 14-Apr-2014
Allogeneic haematopoietic stem cell transplantation (allo-HSCT) is an established treatment option for many malignant and non-malignant disorders. In the past two decades, peripheral blood stem cells replaced bone marrow as stem cell source due to faster
- Bone morphogenetic protein (BMP) for fracture healing in adults
Cochrane Systematic Reviews, 11-May-2010
Delay in fracture healing is a complex clinical and economic issue for patients and health services.
- Booster dose vaccination for preventing hepatitis B
Cochrane Systematic Reviews, 5-Oct-2010
Antibodies against hepatitis B surface antigen (HBs) wane over time after vaccination for hepatitis B (HB); hence, the duration of protection provided by the vaccine is still unknown but may be evaluated indirectly by measuring the anamnestic immune respo
- Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy (UPDATE)
Cochrane Systematic Reviews, 10-Nov-2009
Cerebral palsy (CP) is "a group of permanent disorders of the development of movement and posture causing activity limitation(s) that are attributed to non-progressive disturbance that occurred in the developing fetal or infant brain" (Rosenbaum 2007, p.9
- Botulinum toxin for masseter hypertrophy
Cochrane Systematic Reviews, 9-Sep-2013
Benign masseter muscle hypertrophy is an uncommon clinical phenomenon of uncertain aetiology which is characterised by a soft swelling near the angle of the mandible. The swelling may on occasion be associated with facial pain and can be prominent enough
- Botulinum toxin for myofascial pain syndromes in adults
Cochrane Systematic Reviews, 28-Jul-2014
This is an updated version of the original Cochrane review published in Issue 4, 2012. Myofascial pain syndrome (MPS) is a regional muscular pain syndrome characterised by the presence of trigger points, which are painful points in one or more muscles. Th
